Meta made its Llama 2 AI model open-source because ‘Zuck has balls,’ a former top Facebook engineer says::Meta CEO Mark Zuckerberg took a big risk by making its powerful AI model Llama 2 mostly open source, according to Replit CEO Amjad Masad.

  • just_another_person@lemmy.world
    link
    fedilink
    English
    arrow-up
    11
    arrow-down
    1
    ·
    10 months ago

    In the AI world it’s a bit different. You can do whatever you want with the model and weights data which will net you the functional part of the resulting product. Train, retrain, dissect, segment…etc. They’re just not giving out the source for the actual engine. The people working with such things really only care about the data, and in most cases, would probably convert it to a different engine anyway.

    • BeefPiano@lemmy.world
      link
      fedilink
      English
      arrow-up
      6
      arrow-down
      1
      ·
      10 months ago

      Can I remake the model only including Creative Commons sourced training material?

      • just_another_person@lemmy.world
        link
        fedilink
        English
        arrow-up
        4
        ·
        edit-2
        10 months ago

        You can reuse the data however you want, yes. You just can’t do it with their proprietary model. So, again, the ENGINE is not open source (the thing that drives their released version), but the model and data as it runs as released you can do whatever you want with.

          • just_another_person@lemmy.world
            link
            fedilink
            English
            arrow-up
            5
            ·
            10 months ago

            Nope. Free for educational, research, or commercial. I’m sure their license has some restrictions on what that actually means once you get to be competitive with the original as a product, but otherwise free unless you start a massive enterprise based on it, at which point you probably wouldn’t use it anyway. It’s just an LLM, it’s not doing anything super special like folding proteins for drug development, or curing cancer.